Yunsung F&C Co Ltd

Yunsung F&C maintains a liquidity position with a current ratio of 1.9 and cash reserves of ₩40.2 billion, but its free cash flow of -₩19.2 billion indicates operational cash outflows. The price-to-book ratio of 1.36 suggests market valuation aligns with tangible asset base, while the debt-to-equity ratio of 0.18 reflects conservative leverage. The company reported a net loss of ₩19.2 billion and operating loss of ₩31.6 billion, with ROE and ROA at -10.8% and -7.2% respectively, significantly below industry benchmarks for machinery manufacturers. Gross profit of ₩168 million on ₩100.2 billion revenue highlights margin compression in its core industrial equipment business. Revenue is concentrated in industrial equipment manufacturing with no disclosed geographic diversification metrics. The company serves secondary battery and biopharma sectors, which represent high-growth but capital-intensive markets. Outlook shows revenue of ₩100.2 billion in the current fiscal year, with no directional guidance provided for the next period. Capital expenditures of -₩3.9 billion suggest ongoing investment in production capabilities. The negative operating cash flow of ₩4.7 billion contrasts with the company's liquidity position, indicating potential working capital challenges. Risk assessment identifies low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and high current ratio support its liquidity profile. No dilution sources were identified in recent filings, and the risk assessment indicates low dilution potential. Recent financial filings show continued operating losses and negative net income. Analyst estimates confirm the company's underperformance relative to revenue expectations, with actual revenue of ₩92.6 billion versus ₩100.2 billion reported.